Literature DB >> 25269804

Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats.

Silvia Balbo1, Charles S Johnson1, Ramesh C Kovi1, Sandra A James-Yi1, M Gerard O'Sullivan1, Mingyao Wang1, Chap T Le1, Samir S Khariwala1, Pramod Upadhyaya1, Stephen S Hecht2.   

Abstract

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is metabolized to enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), found in the urine of virtually all people exposed to tobacco products. We assessed the carcinogenicity in male F-344 rats of (R)-NNAL (5 ppm in drinking water), (S)-NNAL (5 ppm), NNK (5 ppm) and racemic NNAL (10 ppm) and analyzed DNA adduct formation in lung and pancreas of these rats after 10, 30, 50 and 70 weeks of treatment. All test compounds induced a high incidence of lung tumors, both adenomas and carcinomas. NNK and racemic NNAL were most potent; (R)-NNAL and (S)-NNAL had equivalent activity. Metastasis was observed from primary pulmonary carcinomas to the pancreas, particularly in the racemic NNAL group. DNA adducts analyzed were O (2)-[4-(3-pyridyl)-4-oxobut-1-yl]thymidine (O (2)-POB-dThd), 7-[4-(3-pyridyl)-4-oxobut-1-yl]guanine(7-POB-Gua),O (6)-[4-(3-pyridyl)-4-oxobut-1-yl]deoxyguanosine(O (6)-POB-dGuo),the 4-(3-pyridyl)-4-hydroxybut-1-yl(PHB)adductsO (2)-PHB-dThd and 7-PHB-Gua, O (6)-methylguanine (O (6)-Me-Gua) and 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB)-releasing adducts. Adduct levels significantly decreased with time in the lungs of rats treated with NNK. Pulmonary POB-DNA adducts and O (6)-Me-Gua were similar in rats treated with NNK and (S)-NNAL; both were significantly greater than in the (R)-NNAL rats. In contrast, pulmonary PHB-DNA adduct levels were greatest in the rats treated with (R)-NNAL. Total pulmonary DNA adduct levels were similar in (S)-NNAL and (R)-NNAL rats. Similar trends were observed for DNA adducts in the pancreas, but adduct levels were significantly lower than in the lung. The results of this study clearly demonstrate the potent pulmonary carcinogenicity of both enantiomers of NNAL in rats and provide important new information regarding DNA damage by these compounds in lung and pancreas.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25269804      PMCID: PMC4247520          DOI: 10.1093/carcin/bgu204

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  54 in total

1.  Formation and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers in vitro in mouse, rat and human tissues.

Authors:  P Upadhyaya; S G Carmella; F P Guengerich; S S Hecht
Journal:  Carcinogenesis       Date:  2000-06       Impact factor: 4.944

2.  Dose-response study of DNA and hemoglobin adduct formation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats.

Authors:  S E Murphy; A Palomino; S S Hecht; D Hoffmann
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

3.  Linear dose-response relationship for DNA adducts in rat liver from chronic exposure to aflatoxin B1.

Authors:  P Buss; M Caviezel; W K Lutz
Journal:  Carcinogenesis       Date:  1990-12       Impact factor: 4.944

4.  Glucuronidation of 4-((hydroxymethyl)nitrosamino)-1-(3-pyridyl)-1-butanone, a metabolically activated form of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, by phenobarbital-treated rats.

Authors:  S E Murphy; D A Spina; M G Nunes; D A Pullo
Journal:  Chem Res Toxicol       Date:  1995 Jul-Aug       Impact factor: 3.739

5.  Transplacental induction of pancreas tumors in hamsters by ethanol and the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  H M Schüller; R Jorquera; A Reichert; A Castonguay
Journal:  Cancer Res       Date:  1993-06-01       Impact factor: 12.701

6.  Tissue and cell specific methylation, repair and synthesis of DNA in the upper gastrointestinal tract of Wistar rats treated with N-methyl-N'-nitro-N-nitrosoguanidine via the drinking water.

Authors:  N H Zaidi; C S Potten; G P Margison; D P Cooper; P J O'Connor
Journal:  Carcinogenesis       Date:  1993-10       Impact factor: 4.944

7.  Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers.

Authors:  P G Foiles; S A Akerkar; S G Carmella; M Kagan; G D Stoner; J H Resau; S S Hecht
Journal:  Chem Res Toxicol       Date:  1991 May-Jun       Impact factor: 3.739

8.  O6-methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung.

Authors:  L A Peterson; S S Hecht
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

9.  Transplacental carcinogenicity of low doses of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone administered subcutaneously or intratracheally to hamsters.

Authors:  H M Schüller; R Jorquera; X Lu; A Riechert; A Castonguay
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents.

Authors:  Z A Ronai; S Gradia; L A Peterson; S S Hecht
Journal:  Carcinogenesis       Date:  1993-11       Impact factor: 4.944

View more
  29 in total

1.  Analysis and Identification of 2'-Deoxyadenosine-Derived Adducts in Lung and Liver DNA of F-344 Rats Treated with the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol.

Authors:  Erik S Carlson; Pramod Upadhyaya; Peter W Villalta; Bin Ma; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2018-04-19       Impact factor: 3.739

2.  Pyridylhydroxybutyl and pyridyloxobutyl DNA phosphate adduct formation in rats treated chronically with enantiomers of the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.

Authors:  Bin Ma; Adam T Zarth; Erik S Carlson; Peter W Villalta; Irina Stepanov; Stephen S Hecht
Journal:  Mutagenesis       Date:  2017-12-31       Impact factor: 3.000

3.  Quantification of DNA Lesions Induced by 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol in Mammalian Cells.

Authors:  Su Guo; Jiapeng Leng; Ying Tan; Nathan E Price; Yinsheng Wang
Journal:  Chem Res Toxicol       Date:  2019-02-15       Impact factor: 3.739

4.  Mass Spectrometric Quantitation of Pyridyloxobutyl DNA Phosphate Adducts in Rats Chronically Treated with N'-Nitrosonornicotine.

Authors:  Yupeng Li; Bin Ma; Qing Cao; Silvia Balbo; Lijiao Zhao; Pramod Upadhyaya; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2019-02-26       Impact factor: 3.739

Review 5.  Context Matters: Contribution of Specific DNA Adducts to the Genotoxic Properties of the Tobacco-Specific Nitrosamine NNK.

Authors:  Lisa A Peterson
Journal:  Chem Res Toxicol       Date:  2016-12-08       Impact factor: 3.739

6.  Evaluation of Nitrosamide Formation in the Cytochrome P450-Mediated Metabolism of Tobacco-Specific Nitrosamines.

Authors:  Erik S Carlson; Pramod Upadhyaya; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2016-12-06       Impact factor: 3.739

7.  Metastasis to the F344 Rat Pancreas from Lung Cancer Induced by 4-(Methylnitrosamino)- 1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)- 1-butanol, Constituents of Tobacco Products.

Authors:  Ramesh C Kovi; Charles S Johnson; Silvia Balbo; Stephen S Hecht; M Gerard O'Sullivan
Journal:  Toxicol Pathol       Date:  2018-02-01       Impact factor: 1.902

8.  Clinical Trial of 2-Phenethyl Isothiocyanate as an Inhibitor of Metabolic Activation of a Tobacco-Specific Lung Carcinogen in Cigarette Smokers.

Authors:  Jian-Min Yuan; Irina Stepanov; Sharon E Murphy; Renwei Wang; Sharon Allen; Joni Jensen; Lori Strayer; Jennifer Adams-Haduch; Pramod Upadhyaya; Chap Le; Mindy S Kurzer; Heather H Nelson; Mimi C Yu; Dorothy Hatsukami; Stephen S Hecht
Journal:  Cancer Prev Res (Phila)       Date:  2016-03-07

9.  Mass Spectrometric Quantitation of Apurinic/Apyrimidinic Sites in Tissue DNA of Rats Exposed to Tobacco-Specific Nitrosamines and in Lung and Leukocyte DNA of Cigarette Smokers and Nonsmokers.

Authors:  Jiehong Guo; Haoqing Chen; Pramod Upadhyaya; Yingchun Zhao; Robert J Turesky; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2020-09-09       Impact factor: 3.739

10.  Combined analysis of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in the urine of cigarette smokers and e-cigarette users.

Authors:  Delshanee Kotandeniya; Steven G Carmella; Makenzie E Pillsbury; Stephen S Hecht
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-10-31       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.